Skip to content

Organon OGN U.S. — Customer Discount Accrual Related To Sales

Similar metrics at other companies

AZZ logo
AZZAccrued customer discount
$11.59M-6.0%
Lantheus Holdings logo
LNTHAccrued Rebates And Discounts Current
$69.88M
Alkermes logo
ALKSProduct Discounts — Accrued Sales Discounts Allowances And Reserves
$18.7M+21.8%
WD-40 Company logo
WDFCRebate/Other Discounts — Accrued liabilities
$11.8M-20.3%
Alkermes logo
ALKSAccrued Sales Discounts Allowances And Reserves
$272.84M+9.2%
SolarEdge Technologies logo
SEDGAccrual For Sales Incentives
$17.65M+13.1%

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept ogn:CustomerDiscountAccrualRelatedToSales.

The official record: Organon’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's u.s. — customer discount accrual related to sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's U.S. — customer discount accrual related to sales?
Organon (OGN) reported U.S. — customer discount accrual related to sales of $523M in Q4 2025.
How has Organon's U.S. — customer discount accrual related to sales changed year-over-year?
Organon's U.S. — customer discount accrual related to sales increased by 9.0% year-over-year, from $480M to $523M.
What does U.S. — customer discount accrual related to sales mean?
This metric captures the estimated liability for discounts, incentives, and price concessions offered to customers in the U.S. market that are expected to be settled against future sales. It serves as a contra-revenue adjustment used to determine net revenue by accounting for contractual obligations with wholesalers, pharmacies, and healthcare providers. Monitoring this helps evaluate the impact of pricing strategies and commercial incentives on top-line performance.